Project Grant R01AI195638
Award Date 2/17/26
Completion Date 1/31/31
Dollars Obligated $853K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Children's Hospital of Philadelphia $881,303 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 17, 2025, for a project extending through June 30, 2030. This Project Grant funds a comprehensive research initiative utilizing whole genome sequencing (WGS) and diagnostic allele (DA) surveillance to track pathogen transmission and infection dynamics in neonatal...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Children's Hospital of Philadelphia Research Institute a Project Grant of $812,200 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2030. This five-year research initiative investigates the role of enterococci bacteria in modulating Clostridioides difficile infection (CDI) virulence and disease outcomes. The project employs...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Children's Hospital of Philadelphia (CHOP) a Project Grant of $187,056 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective July 7, 2025, with a completion date of June 30, 2030. This research project investigates erythrocyte glycolysis as a novel antimalarial strategy to address the urgent global health threat posed by artemisinin-resistant Plasmodium...
- Federal Project Grant Award Summary The Children's Hospital of Philadelphia Research Institute received a $670,017 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 4, 2026 through January 31, 2031. This research project investigates a novel regulatory pathway in innate type 2 lymphocytes (ILC2s) that controls cytokine sensing and immune response in allergic...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $489,500 to The Children's Hospital of Philadelphia Research Institute on June 11, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This two-year project, which extends through May 31, 2027, focuses on developing novel sequencing methodologies and analytical pipelines to identify and characterize intact human immunodeficiency virus (HIV) reservoir cells...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Boston Children's Hospital $151,040 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on December 4, 2025, to support a project extending through July 31, 2028. This Project Grant funds basic science research investigating the regulatory mechanisms of a small regulatory RNA (sRNA) designated BECO in Pseudomonas aeruginosa, a gram-negative bacterium that causes serious...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Children's Hospital of Philadelphia Research Institute a $534,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 23, 2025, with a completion date of June 30, 2030. The project, "Decoding Multidrug-Resistant Pathogen Dynamics for Clinically-Relevant Wastewater Surveillance," develops innovative wastewater monitoring systems...
- Federal Grant Award Summary This $122,472 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research conducted by Boston Children's Hospital to elucidate the molecular mechanisms of NLRP3 inflammasome activation and regulation. The award, obligated on August 13, 2025, with a completion date of July 31, 2027, funds a structured research initiative consisting of a K99...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Boston Children's Hospital $800,557 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective February 19, 2026, with a completion date of January 31, 2031. This project grant supports biomedical research investigating how the gram-positive pathogen Staphylococcus aureus manipulates inflammasome activities critical to host immune defense. The research focuses...
- Federal Grant Award Summary St. Jude Children's Research Hospital Inc. received a $151,040 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective March 1, 2026, with a completion date of October 31, 2028. The award funds research on "Strategies and Consequences of Polymicrobial Nasal Colonization," investigating how multiple bacterial species interact within the upper...